Sort
21,281 grants matching “influenza”
Discovery and Development of Oral Small-molecule Direct-acting Antivirals for Influenza
$498,199Juan Pizarro · · N43 · FY2025 · AI
A Novel First-in-class 3D Printing Technology for Advanced Manufacturing of Complex Vaccine Formulations against Influenza and Emerging Infectious Diseases
$498,189Mohammed Maniruzzaman · University Of Texas At Austin · R01 · FY2021 · FD
Balancing Airway Progenitor versus Progeny: a Pathway from Mitochondria
$498,170Xin Sun · University Of California, San Diego · R01 · FY2024 · HL
A Novel First-in-class 3D Printing Technology for Advanced Manufacturing of Complex Vaccine Formulations against Influenza and Emerging Infectious Diseases
$498,119Mohammed Maniruzzaman · University Of Mississippi · R01 · FY2023 · FD
Early Responses to Influenza A Virus Replication In Vivo
$498,044Ryan Langlois · University Of Minnesota · R01 · FY2020 · AI
AFIX-OB: A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake
$498,041Saad B. Omer · Yale University · U01 · FY2020 · IP
Washington National Primate Research Center
$497,960David M Anderson · University Of Washington · P51 · FY2015 · OD
Containing Bioterroist and Emerging Infectious Diseases
$497,877Ira M Longini · Fred Hutchinson Cancer Research Center · U01 · FY2006 · GM
Monoclonal Antibody Technology Core
$497,827Patrick Christopher Wilson · Icahn School Of Medicine At Mount Sinai · P01 · FY2012 · AI
Antimicrobial Peptides and Innate Immunity in Otitis Media
$497,778Lauren O Bakaletz · Research Inst Nationwide Children'S Hosp · R01 · FY2010 · DC
SUSTAINING AND ENHANCEMENT OF INFLUENZA SURVEILLANCE AND RESPONSE
$497,773Anna Sominina · Fgbu Nii Grippa Minzdrava Rossii · U51 · FY2011 · IP
SUSTAINING AND ENHANCEMENT OF INFLUENZA SURVEILLANCE AND RESPONSE
$497,773Anna Sominina · Fgbu Nii Grippa Minzdrava Rossii · U51 · FY2012 · IP
Mechanisms of regulatory T cell-mediated recovery from severe influenza A virus infection
$497,758Benjamin David Singer · Northwestern University At Chicago · R01 · FY2023 · HL
Monoclonal Antibody Technology Core
$497,686Patrick Christopher Wilson · Icahn School Of Medicine At Mount Sinai · P01 · FY2016 · AI
Paired genomics and proteomics point-of-care platform for infectious diseases diagnostics
$497,674Erwin Berthier · Tasso, Inc. · R44 · FY2015 · DK
Enhanced Surveillance: New Vaccine Preventable Diseases
$497,561Kathryn Margaret Edwards · Vanderbilt University · U01 · FY2010 · IP
Mucosal Memory T Cells at the Vanguard of Human Host Defense
$497,557Donna L Farber · Columbia University Health Sciences · RC1 · FY2010 · AI
Rapid, single-dose coronavirus vaccines via DNA-launched nanoparticles and genetic adjuvants for durable anti-coronavirus immunity
$497,477David B. Weiner · Wistar Institute · P01 · FY2025 · AI
Longitudinal dynamics of protection after influenza infection and vaccination
$497,337Sarah Cobey · University Of Chicago · R01 · FY2019 · AI
AFIX-OB: A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake
$497,109Saad B. Omer · Yale University · U01 · FY2019 · IP
Computational Approaches for Prediction and Design of Human Influenza Abs
$497,102Jens Meiler · Vanderbilt University Medical Center · U19 · FY2019 · AI
Enhancing mammalian glycoprotein production in the baculovirus expression vector
$497,092Angelika Fath-Goodin · Paratechs Corp. · R44 · FY2013 · GM
HIV neutralization and mechanisms of cellular entry
$497,025Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Role of type III interferons in Staphylococcus aureus respiratory tract infection
$496,961Dane Parker · Rbhs-New Jersey Medical School · R01 · FY2020 · HL
Role of type III interferons in Staphylococcus aureus respiratory tract infection
$496,961Dane Parker · Rbhs-New Jersey Medical School · R01 · FY2019 · HL